Researchers using FDG-PET have uncovered healthy patterns of glucose metabolism in the brains of people at risk for Alzheimer’s disease who consistently partake in moderate-intensity physical activity, according to a study published online June 22 in the Journal of Alzheimer’s Disease. {read more here}

A new brain imaging study [PET] by the Centre for Addiction and Mental Health (CAMH) shows for the first time that brain inflammation is significantly elevated – more than 30 per cent higher – in people with obsessive-compulsive disorder (OCD) than in people without the condition. Published today in JAMA Psychiatry, the study provides compelling evidence for a new potential direction for treating this anxiety disorder, which can be debilitating for people who experience it. {read more here}

We are now entering into a new era, wherein we clinically have the capability of creating images of the functioning brain. This is the focus of nuclear neurology (NN), a 21st century diagnostic field now available for clinical medicine. {read more here}

The company plans to work with pharmaceutical partners to evaluate the product’s use in positron emission tomography scans to assess neurofibrillary tangles in the brain. NFTs composed of aggregated tau protein are characteristic of certain neurodegenerative conditions like Alzheimer’s disease. {read more here}